Weight-loss solutions designed to transform and sustain
Longevity medications designed to extend and enhance
If approved, Shed can provide access to Zepbound® (tirzepatide) in a vial, fulfilled by a dispensing pharmacy and delivered straight to your door.
Wegovy® (semaglutide) is an FDA-approved prescription medication used for chronic weight management in adults with obesity or excess weight. It belongs to a class of medications called GLP-1 receptor agonists.
Wegovy® works by mimicking a natural hormone in your body that helps regulate appetite and blood sugar, which can support reduced food intake and healthier eating patterns when combined with lifestyle changes.
Wegovy® has been clinically studied for weight management. In clinical trials, adults who used Wegovy® alongside diet and lifestyle changes lost an average of 14–15% of their body weight over one year.*
Individual results vary based on factors such as dosage, adherence, lifestyle habits, and overall health.
Both the Wegovy® pill and the Wegovy® pen contain the same active ingredient, semaglutide, and are FDA-approved for weight management. The main difference is how and how often they’re taken.
Similarities:
Differences:
Your Shed provider will help determine which option may be appropriate based on your health history, preferences, and treatment goals.
Both medications contain semaglutide, but they are FDA-approved for different uses.
In some cases, providers may prescribe Ozempic® off-label for weight management when appropriate, but Wegovy® is the formulation designed and approved for weight loss.






Wegovy® is now available as a once-daily pill, offering a needle-free option for people who prefer oral medication. Like the Wegovy® pen, the pill contains semaglutide and is FDA-approved for chronic weight management.
This new delivery method gives patients more flexibility in how they take Wegovy®, while still receiving provider-guided care through Shed.

*In clinical trials of Wegovy® (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise. This compares to approximately 2–3% weight loss with diet and exercise alone.

















Wegovy® (semaglutide) is an FDA-approved prescription medication used for chronic weight management in adults with obesity or excess weight. It belongs to a class of medications called GLP-1 receptor agonists.
Wegovy® works by mimicking a natural hormone in your body that helps regulate appetite and blood sugar, which can support reduced food intake and healthier eating patterns when combined with lifestyle changes.
Wegovy® has been clinically studied for weight management. In clinical trials, adults who used Wegovy® alongside diet and lifestyle changes lost an average of 14–15% of their body weight over one year.*
Individual results vary based on factors such as dosage, adherence, lifestyle habits, and overall health.
Both the Wegovy® pill and the Wegovy® pen contain the same active ingredient, semaglutide, and are FDA-approved for weight management. The main difference is how and how often they’re taken.Similarities:
Differences:
Your Shed provider will help determine which option may be appropriate based on your health history, preferences, and treatment goals.
Both medications contain semaglutide, but they are FDA-approved for different uses.
In some cases, providers may prescribe Ozempic® off-label for weight management when appropriate, but Wegovy® is the formulation designed and approved for weight loss.
Shed provides access to Wegovy® through a fully online, provider-led care model.
If prescribed, your program includes:
Medication costs are separate from the monthly Shed membership.
Zepbound® pricing starts at $349 per month for new patients using cash pay. Prices do not include the $99 Shed membership and provider fee, which is paid directly to Shed. Medication costs are paid separately to the dispensing pharmacy.
Zepbound® (tirzepatide) is FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Results vary by individual and are not guaranteed. Weight loss depends on factors such as diet, exercise, adherence, medical history, and individual response.
Providers may evaluate patients and prescribe Zepbound® when clinically appropriate. Prescriptions are based on a medical evaluation and are at the provider’s discretion.
Shed is not a pharmacy and does not dispense medications. Prescriptions are fulfilled and shipped by a third-party pharmacy. Medications carry risks and side effects (hyperlink to SE page). Patients should review the full prescribing information and discuss risks with their provider.
Zepbound® is a registered trademark of Eli Lilly and Company. Shed is not affiliated with or endorsed by Eli Lilly and Company.




If approved, Shed can provide access to Zepbound® (tirzepatide) in a vial, fulfilled by a dispensing pharmacy and delivered straight to your door.




If approved, Shed can provide access to Zepbound® (tirzepatide) in a vial, fulfilled by a dispensing pharmacy and delivered straight to your door.




Doctor of Medicine (MD),
Internal Medicine Physician
While GLP-1 microdosing is ideal for maintenance, longevity, and overall wellness support, those with a significant weight-loss goal may be better suited for a standard GLP-1 dose.

Zepbound® pricing starts at $349 per month for new patients using cash pay. Prices do not include the $99 Shed membership and provider fee, which is paid directly to Shed. Medication costs are paid separately to the dispensing pharmacy.
Zepbound® (tirzepatide) is FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Results vary by individual and are not guaranteed. Weight loss depends on factors such as diet, exercise, adherence, medical history, and individual response.
Providers may evaluate patients and prescribe Zepbound® when clinically appropriate. Prescriptions are based on a medical evaluation and are at the provider’s discretion.
Shed is not a pharmacy and does not dispense medications. Prescriptions are fulfilled and shipped by a third-party pharmacy. Medications carry risks and side effects (hyperlink to SE page). Patients should review the full prescribing information and discuss risks with their provider.
Zepbound® is a registered trademark of Eli Lilly and Company. Shed is not affiliated with or endorsed by Eli Lilly and Company.
Weight-loss solutions designed to transform and sustain
Longevity medications designed to extend and enhance